Viking Therapeutics, Inc. (VKTX) — Net Income

Annual figures by fiscal year, from SEC filings.

2014: -$21.88M2015: -$23.40M2016: -$14.73M2017: -$20.58M2018: -$22.06M2019: -$25.78M2020: -$39.49M2021: -$54.99M2022: -$68.87M2023: -$85.89M2024: -$109.96M2025: -$359.64M-$359.64M
2014Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025-$359.64M-227.1%
2024-$109.96M-28.0%
2023-$85.89M-24.7%
2022-$68.87M-25.2%
2021-$54.99M-39.2%
2020-$39.49M-53.2%
2019-$25.78M-16.8%
2018-$22.06M-7.2%
2017-$20.58M-39.7%
2016-$14.73M+37.1%
2015-$23.40M-6.9%
2014-$21.88M